JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayer, J. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mayer, J. E., Jr
Related Collections
Right arrow Molecular biology

J Thorac Cardiovasc Surg 2003;125:S14-S15
© 2003 The American Association for Thoracic Surgery


Editorials

In search of the ideal valve replacement device

John E. Mayer, Jr, MD

From The Children's Hospital, Boston, Mass.

Received for publication March 7, 2001. Accepted for publication March 20, 2001. Address for reprints: John E. Mayer, MD, The Children's Hospital Boston, 300 Longwood Ave, Boston, MA 02115 (E-mail: john.meyer@tch.harvard.edu).

The first 20% of the full text of this article appears below.

The search for an ideal cardiac valve replacement began in the earliest days of cardiac surgery, and the commandments describing the essential characteristics of an ideal valve replacement device were outlined by Dwight HarkenGo 1 in the 1950s. These characteristics include durability, absence of thrombogenicity, resistance to the ability to provide normal hemodynamics, absence of damage to blood elements, and technical practicality of insertion in a physiologic position in the circulation. Additional desirable characteristics include resistance to infection and lack of immunogenicity. If valves are to be used in children, the capacity for growth must be included as well. Many prosthetic and bioprosthetic valves provide good hemodynamic performance with low gradients and insignificant regurgitation. However, no prosthetic valve will be able to meet the nonthrombogenicity criterion because a nonthrombogenic, blood-compatible surface has not yet been developed. All prosthetic . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The American Association for Thoracic Surgery.